Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • INTU vs MRNA✓SelectedUSD · MRNAINTU vs MRNA performance historyLatest closeAs of+1.13%11/16
Stock and ETF performance explorer

INTU vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-13.5%
MRNA return
+330.7%
Excess return
-344.2%
Maximum drawdown
-36.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.1%-3.6%+4.8%+1.2%
7D+2.2%-20.0%+22.1%+2.5%
30D+6.3%-1.3%+7.5%+6.2%
3M+0.4%+240.0%-239.5%-3.3%
All-13.5%+330.7%-344.2%-17.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling